These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 26253764)

  • 1. A common glycan structure on immunoglobulin G for enhancement of effector functions.
    Lin CW; Tsai MH; Li ST; Tsai TI; Chu KC; Liu YC; Lai MY; Wu CY; Tseng YC; Shivatare SS; Wang CH; Chao P; Wang SY; Shih HW; Zeng YF; You TH; Liao JY; Tu YC; Lin YS; Chuang HY; Chen CL; Tsai CS; Huang CC; Lin NH; Ma C; Wu CY; Wong CH
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10611-6. PubMed ID: 26253764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal Structure of a Homogeneous IgG-Fc Glycoform with the N-Glycan Designed to Maximize the Antibody Dependent Cellular Cytotoxicity.
    Chen CL; Hsu JC; Lin CW; Wang CH; Tsai MH; Wu CY; Wong CH; Ma C
    ACS Chem Biol; 2017 May; 12(5):1335-1345. PubMed ID: 28318221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.
    Quast I; Keller CW; Maurer MA; Giddens JP; Tackenberg B; Wang LX; Münz C; Nimmerjahn F; Dalakas MC; Lünemann JD
    J Clin Invest; 2015 Nov; 125(11):4160-70. PubMed ID: 26436649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of terminal galactose residues in mannose α1-6 arm of Fc-glycan on the effector functions of therapeutic monoclonal antibodies.
    Aoyama M; Hashii N; Tsukimura W; Osumi K; Harazono A; Tada M; Kiyoshi M; Matsuda A; Ishii-Watabe A
    MAbs; 2019 Jul; 11(5):826-836. PubMed ID: 30990348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycoengineered Monoclonal Antibodies with Homogeneous Glycan (M3, G0, G2, and A2) Using a Chemoenzymatic Approach Have Different Affinities for FcγRIIIa and Variable Antibody-Dependent Cellular Cytotoxicity Activities.
    Kurogochi M; Mori M; Osumi K; Tojino M; Sugawara S; Takashima S; Hirose Y; Tsukimura W; Mizuno M; Amano J; Matsuda A; Tomita M; Takayanagi A; Shoda S; Shirai T
    PLoS One; 2015; 10(7):e0132848. PubMed ID: 26200113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality.
    Scallon BJ; Tam SH; McCarthy SG; Cai AN; Raju TS
    Mol Immunol; 2007 Mar; 44(7):1524-34. PubMed ID: 17045339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terminal sugars of Fc glycans influence antibody effector functions of IgGs.
    Raju TS
    Curr Opin Immunol; 2008 Aug; 20(4):471-8. PubMed ID: 18606225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoenzymatic Glyco-engineering of Monoclonal Antibodies.
    Giddens JP; Wang LX
    Methods Mol Biol; 2015; 1321():375-87. PubMed ID: 26082235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of differential glycosylation on IgG activity.
    Lux A; Nimmerjahn F
    Adv Exp Med Biol; 2011; 780():113-24. PubMed ID: 21842369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel roles for the IgG Fc glycan.
    Anthony RM; Wermeling F; Ravetch JV
    Ann N Y Acad Sci; 2012 Apr; 1253():170-80. PubMed ID: 22288459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions.
    Huang W; Giddens J; Fan SQ; Toonstra C; Wang LX
    J Am Chem Soc; 2012 Jul; 134(29):12308-18. PubMed ID: 22747414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of stage-dependent glycans on the Fc domains of IgG antibodies of ALS animals.
    Edri-Brami M; Sharoni H; Hayoun D; Skutelsky L; Nemirovsky A; Porgador A; Lichtenstein RG
    Exp Neurol; 2015 May; 267():95-106. PubMed ID: 25725350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating IgG effector function by Fc glycan engineering.
    Li T; DiLillo DJ; Bournazos S; Giddens JP; Ravetch JV; Wang LX
    Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3485-3490. PubMed ID: 28289219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Method to Detect the Binding of Hyper-Glycosylated Fragment Crystallizable (Fc) Region of Human IgG1 to Glycan Receptors.
    Blundell P; Pleass R
    Methods Mol Biol; 2019; 1904():417-421. PubMed ID: 30539483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.
    Kaneko Y; Nimmerjahn F; Ravetch JV
    Science; 2006 Aug; 313(5787):670-3. PubMed ID: 16888140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.
    Anthony RM; Ravetch JV
    J Clin Immunol; 2010 May; 30 Suppl 1():S9-14. PubMed ID: 20480216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering host cell lines to reduce terminal sialylation of secreted antibodies.
    Naso MF; Tam SH; Scallon BJ; Raju TS
    MAbs; 2010; 2(5):519-27. PubMed ID: 20716959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for improved efficacy of therapeutic antibodies on defucosylation of their Fc glycans.
    Mizushima T; Yagi H; Takemoto E; Shibata-Koyama M; Isoda Y; Iida S; Masuda K; Satoh M; Kato K
    Genes Cells; 2011 Nov; 16(11):1071-80. PubMed ID: 22023369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.